Light affects sleep indirectly by entraining the circadian clock, but also directly and rapidly via a phenomenon known as the masking or direct effect of light on behavior. Masking refers to the observation that light exposure at night induces sleep in nocturnal animals and suppresses sleep in diurnal animals, including humans, whereas dark exposure during the day inhibits sleep in nocturnal animals. While masking is widespread in the animal kingdom, the mechanisms that mediate masking are largely unknown. Understanding mechanisms that regulate sleep is important because over 10% of Americans suffer from chronic sleep disorders that have poor therapeutic options and cause an annual economic burden of $100 billion. Understanding how masking in particular affects sleep is important because at least some of the sleep disruption observed in modern societies results from masking due to widespread exposure to artificial light at night. Our preliminary experiments using zebrafish suggest that the neuropeptide prokineticin 2 (Prok2) regulates masking. To our knowledge, this is the first gene shown to regulate masking beyond the initial step of light detection by melanopsin in the retina, and thus it provides a foothold to explore the genetic and neurological mechanisms through which light directly affects sleep. Although a similar phenotype was observed in rodents, a role in masking was not explored, and the developmental defects of prok2 mutant mice confound sleep studies. The zebrafish is a vertebrate model that exhibits behavioral, anatomical, genetic and pharmacological conservation of mammalian sleep. While the zebrafish has some limitations as a sleep model, its amenability to genetic, optogenetic and pharmacological approaches, as well as its transparency and relatively simple yet conserved vertebrate brain, and the lack of developmental defects in prok2 mutant animals, provide advantages for sleep studies that we exploit in this proposal. The zebrafish is particularly appropriate for studying mechanisms that may underlie masking in humans because it is a diurnal vertebrate.
In Specific Aim 1 we use gain- and loss-of-function genetics, as well as optogenetic and chemogenetic tools, to test the hypotheses that Prok2 and prok2-expressing neurons regulate masking. We also test whether our findings for Prok2 apply to other peptides that have been proposed to regulate behavior in a manner similar to Prok2.
In Specific Aim 2, we explore potential mechanisms through which Prok2 regulates masking, such as by regulating the activity of the noradrenergic locus coeruleus (Aim 2A), the expression of the sleep-promoting neuropeptide galanin in the hypothalamus (Aim 2B) or other sleep regulatory pathways. These studies will for the first time identify genes and neurons in the brain that regulate masking, and thus provide a basis to study the genetic and neurological mechanisms that underlie this phenomenon. Because Prok2 acts via G-protein coupled receptors, which are amenable to small molecule modulation, this work may eventually lead to novel therapies for sleep disorders and for neuropsychiatric disorders that are exacerbated by disrupted sleep.

Public Health Relevance

Over 10% of humans suffer from chronic sleep disorders, but the causes of most of these disorders are unknown and effective therapies are lacking. With the widespread use of artificial light at night, it is likely that a significant portion of sleep disorders result from masking effects, which refers to the direct effect of light and dark on sleep and wakefulness. We will explore genetic and neurological mechanisms that underlie masking, which may eventually lead to novel therapies for some sleep disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS095824-05
Application #
10056992
Study Section
Neurodifferentiation, Plasticity, and Regeneration Study Section (NDPR)
Program Officer
He, Janet
Project Start
2016-12-01
Project End
2021-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
5
Fiscal Year
2021
Total Cost
Indirect Cost
Name
California Institute of Technology
Department
Type
Schools of Arts and Sciences
DUNS #
009584210
City
Pasadena
State
CA
Country
United States
Zip Code
91125
Prober, David A (2018) Discovery of Hypocretin/Orexin Ushers in a New Era of Sleep Research. Trends Neurosci 41:70-72
Jaggard, James B; Stahl, Bethany A; Lloyd, Evan et al. (2018) Hypocretin underlies the evolution of sleep loss in the Mexican cavefish. Elife 7:
Chen, Audrey; Singh, Chanpreet; Oikonomou, Grigorios et al. (2017) Genetic Analysis of Histamine Signaling in Larval Zebrafish Sleep. eNeuro 4:
Oikonomou, Grigorios; Prober, David A (2017) Attacking sleep from a new angle: contributions from zebrafish. Curr Opin Neurobiol 44:80-88
Chen, Shijia; Reichert, Sabine; Singh, Chanpreet et al. (2017) Light-Dependent Regulation of Sleep and Wake States by Prokineticin 2 in Zebrafish. Neuron 95:153-168.e6
Singh, Chanpreet; Rihel, Jason; Prober, David A (2017) Neuropeptide Y Regulates Sleep by Modulating Noradrenergic Signaling. Curr Biol 27:3796-3811.e5
Lee, Daniel A; Andreev, Andrey; Truong, Thai V et al. (2017) Genetic and neuronal regulation of sleep by neuropeptide VF. Elife 6:
Suarez-Bregua, Paula; Torres-Nuñez, Eva; Saxena, Ankur et al. (2017) Pth4, an ancient parathyroid hormone lost in eutherian mammals, reveals a new brain-to-bone signaling pathway. FASEB J 31:569-583
Nath, Ravi D; Bedbrook, Claire N; Abrams, Michael J et al. (2017) The Jellyfish Cassiopea Exhibits a Sleep-like State. Curr Biol 27:2984-2990.e3